Management of primary and secondary non-responders to B cell depletion therapy in systemic lupus erythematosus: Results from the first 100 patients at a single centre

被引：0
|
作者：
Yusof, M. Y. Md [1 ,2 ]
Shaw, D. [1 ]
El-Sherbiny, Y. [1 ,2 ]
Dass, S. [1 ,2 ]
Savic, S. [1 ,2 ]
Rawstron, A. C. [1 ,3 ]
Vital, E. M. [1 ,2 ]
Emery, P. [1 ,2 ]
机构：
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Unit, Leeds, W Yorkshire, England
[3] Leeds Teaching Hosp NHS Trust, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4.05
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 39 条
  • [1] MANAGEMENT OF PRIMARY AND SECONDARY NON-RESPONSE TO B CELL DEPLETION THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS: 10-YEAR EXPERIENCE AT A SINGLE CENTRE
    Yusof, M. Y. Md
    Shaw, D.
    El-Sherbiny, Y.
    Dass, S.
    Rawstron, A. C.
    Vital, E. M.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 338 - 338
  • [2] B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus
    Podolskaya, A.
    Stadermann, M.
    Pilkington, C.
    Marks, S. D.
    Tullus, K.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2008, 93 (05) : 401 - 406
  • [3] HUMANIZED ANTI-CD20 ANTIBODIES IMPROVE DEPLETION AND RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH RESISTANCE TO RITUXIMAB: RESULTS FROM THE FIRST 100 PATIENTS AT A SINGLE CENTRE
    Yusof, Md Yuzaiful Md
    Cassamoali, Huma
    Rawstron, Andy C.
    Hawkins, Tina
    Dunn, Emma
    Emery, Paul
    Vital, Edward M.
    RHEUMATOLOGY, 2016, 55 : 46 - 47
  • [4] Successful Treatment of Recurrent Pancreatitis Secondary to Systemic Lupus Erythematosus with B-cell Depletion Therapy
    Al-Musawi, Zakiya S.
    Nabar, Umesh J.
    ARCHIVES OF IRANIAN MEDICINE, 2011, 14 (01) : 66 - 70
  • [5] Effect of B cell depletion therapy on the anticardiolipin antibody profiles in patients with systemic lupus erythematosus
    Ioannou, Y.
    Cambridge, G. A.
    Rahman, A.
    Leandro, M. J.
    Edwards, J. C. W.
    Isenberg, D. A.
    RHEUMATOLOGY, 2006, 45 : I167 - I167
  • [6] B cell depletion therapy in patients with systemic lupus erythematosus (SLE): Long term follow up and predictors of response
    Ng, K. P.
    Cambridge, G.
    Leandro, M. J.
    Edwards, J. C.
    Ehrenstein, M.
    Isenberg, D. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 56 - 57
  • [7] B cell depletion therapy for patients with systemic lupus erythaematosus results in a significant drop in anticardiolipin antibody titres
    Ioannou, Y.
    Lambrianides, A.
    Cambridge, G.
    Leandro, M. J.
    Edwards, J. C. W.
    Isenberg, D. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) : 425 - 426
  • [8] Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus Who Are in Longterm Remission After B Cell Depletion Therapy with Rituximab
    Iwata, Shigeru
    Saito, Kazuyoshi
    Tokunaga, Mikiko
    Yamaoka, Kunihiro
    Nawata, Masao
    Yukawa, Sonosuke
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Miyagawa, Ippei
    Kubo, Satoshi
    Tanaka, Yoshiya
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (04) : 633 - 641
  • [9] PHENOTYPIC CHANGES OF LYMPHOCYTES IN PATIENTS WITH SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH AN INTENSIFIED B-CELL DEPLETION THERAPY WITH RITUXIMAB
    Sciascia, S.
    Baldovino, S.
    Menegatti, E.
    Solfietti, L.
    Di Simone, D.
    Rossi, D.
    Roccatello, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 560 - 560
  • [10] PREDICTING AND MANAGING PRIMARY AND SECONDARY NON-RESPONSE TO RITUXIMAB USING B-CELL BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Yusof, M. Y. Md
    Shaw, D.
    El-Sherbiny, Y. M.
    Rawstron, A. C.
    Emery, P.
    Vital, E. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 869 - 869
1234